KPMG, in partnership with the Private Directors Association (PDA), and Launch Chapel Hill, is proud to sponsor ‘From Startup to Scale-Up: Financial Governance Essentials’. The Private Directors ...

NC State's Biomanufacturing Training and Education Center is hosting a free, one-day seminar featuring Blue Line and Nymi. Discover how mobile IT and passwordless authentication solutions are ...

Join the Yokogawa Life Science team at NC State's Biomanufacturing Training and Education Center (BTEC) for a seminar on "Accelerating Bioprocess Innovation Through Intelligent Automation and Digital ...

Join NCBiotech's Life Sciences Marketing Group on Nov. 4 for a webinar on The SEO Evolution: Understanding the Impacts of of ...

Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its ...

Join the North Carolina Regulatory Affairs Forum for its annual Rountable Dinner on Nov. 13. This event will feature a networking reception, followed by discussions at multiple tables. Each table will ...

Hosted by the RNA Discovery Center and the UNC Chapel Hill Department of Pharmacology, a screening of the new film "Cracking the Code: Phil Sharp and the Biotech Revolution," will be held on Oct. 22.

Parexel, a clinical research organization (CRO) providing clinical and consulting solutions to the life sciences industry, has opened its new global headquarters in Raleigh’s North Hills Innovation ...

Durham-based BioCryst Pharmaceuticals Inc. plans to acquire Boston-based Astria Therapeutics Inc., adding the late-stage hereditary angioedema (HAE) treatment, navenibart, to its portfolio. The ...

Hear directly from UNC faculty who’ve successfully navigated the commercialization process through startups, licensing, or industry partnerships. This engaging discussion will offer practical insights ...

Priovant announces positive Phase 3 results for targeted dermatomyositis treatment Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR ...